Pharmacokinetics, Efficacy, and Safety of a SARS-CoV-2 Antibody Treatment in Pediatric Participants: An Open-Label Addendum of a Placebo-Controlled, Randomized Phase 2/3 Trial

被引：0
|
作者：
Himanshu P. Upadhyaya
Jenny Y. Chien
Amanda J. Long
Martin S. Bohm
Nicole L. Kallewaard
Lisa F. Macpherson
Dipak R. Patel
Matthew M. Hufford
Constance J. Krull
Jocelyn Y. Ang
Peter Chen
William J. Muller
Jeffrey A. Potts
Timothy Quinn
Mark Williams
机构：
[1] Eli Lilly and Company,
[2] Children’s Hospital of Michigan,undefined
[3] Cedars–Sinai Medical Center,undefined
[4] Ann & Robert H. Lurie Children’s Hospital of Chicago and Northwestern University Feinberg School of Medicine,undefined
[5] Great Lakes Research Group,undefined
[6] Sky Clinical Research Network Group,undefined
[7] Central Michigan University,undefined
来源：
Infectious Diseases and Therapy | 2023年 / 12卷
关键词：
Bamlanivimab; COVID-19; Etesevimab; Monoclonal antibodies; Pediatric; Pharmacokinetics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1861 / 1873
页数：12
相关论文
共 50 条
  • [41] Pharmacokinetics of Staccato® alprazolam in healthy adult participants in two phase 1 studies: An open-label smoker study and a randomized, placebo-controlled ethnobridging study
    Hayakawa, Yoshinobu
    Rospo, Chiara
    Bartmann, Ana Paula
    King, Aliceson
    Roebling, Robert
    Chanteux, Hugues
    [J]. EPILEPSIA, 2024, 65 (04) : 887 - 899
  • [42] Safety and efficacy of the intranasal spray SARS-CoV-2 vaccine dNS1-RBD: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
    Zhu, Fengcai
    Huang, Shoujie
    Liu, Xiaohui
    Chen, Qi
    Zhuang, Chunlan
    Zhao, Hui
    Han, Jinle
    Jaen, Anjuli May
    Do, Thai Hung
    Peter, Jonathan Grant
    Dorado, Alexander Gonzalez
    Tirador, Louie S.
    Zabat, Gelza Mae A.
    Villalobos, Ralph Elvi M.
    Gueco, Gemalyn Pineda
    Botha, Lauren Livia Greta
    Pertuz, Shirley Patricia Iglesias
    Tan, Jiaxiang
    Zhu, Kongxin
    Quan, Jiali
    Lin, Hongyan
    Huang, Yue
    Jia, Jizong
    Chu, Xiafei
    Chen, Junyu
    Chen, Yixin
    Zhang, Tianying
    Su, Yingying
    Li, Changgui
    Ye, Xiangzhong
    Wu, Ting
    Zhang, Jun
    Xia, Ningshao
    [J]. LANCET RESPIRATORY MEDICINE, 2023, 11 (12): : 1075 - 1088
  • [43] Safety and immunogenicity of multivalent SARS-CoV-2 protein vaccines: a randomized phase 3 trial
    Hannawi, Suad
    Yan, Lixin
    Saifeldin, Linda
    Abuquta, Alaa
    Alamadi, Ahmad
    Mahmoud, Sally A.
    Hassan, Aala
    Zhang, Miaomiao
    Gao, Cuige
    Chen, Yuanxin
    Gai, Wenlin
    Xie, Liangzhi
    [J]. ECLINICALMEDICINE, 2023, 64
  • [44] Efficacy and Safety of Pregabalin in Japanese Patients with Fibromyalgia: A Randomized, Double-Blind, Multicenter, Placebo-Controlled Phase III Trial and Open-Label Extension Study
    Ohta, Hiroyoshi
    Ohkura, Masayuki
    Suzuki, Makoto
    Oka, Hiroshi
    Usui, Chie
    Nishioka, Kusuki
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S792 - S792
  • [45] Commentary on "Efficacy and Safety of PrabotulinumtoxinA in Subjects With Benign Masseteric Hypertrophy: A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase 3 Trial and Open-Label Extension Study"
    Hausauer, Amelia K.
    [J]. DERMATOLOGIC SURGERY, 2024, 50 (06) : 534 - 534
  • [46] SARS-CoV-2 viral dynamics in a placebo-controlled phase 2 study of patients infected with the SARS-CoV-2 Omicron variant and treated with pomotrelvir
    Borroto-Esoda, Katyna
    Wilfret, David
    Tong, Xiao
    Plummer, Andrew
    Kearney, Brian
    Kwong, Ann D.
    [J]. MICROBIOLOGY SPECTRUM, 2024, 12 (02):
  • [47] A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial
    Murat Akova
    Serhat Unal
    [J]. Trials, 22
  • [48] A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial
    Akova, Murat
    Unal, Serhat
    [J]. TRIALS, 2021, 22 (01)
  • [49] DESIGN OF A GLOBAL PHASE 2/3 RANDOMIZED, PLACEBO-CONTROLLED TRIAL EVALUATING THE EFFICACY AND SAFETY OF RAVULIZUMAB IN ADULTS WITH DERMATOMYOSITIS
    Cavagna, L.
    Aggarwal, R.
    Iikuni, N.
    Rakhade, S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1750 - 1751
  • [50] Efficacy and safety of oral nalbuphine extended release in prurigo nodularis: Results of a phase 2 randomized controlled trial with an open-label extension phase
    Weisshaar, Elke
    Szepietowski, Jacek C.
    Sciascia, Thomas R.
    Yosipovitch, Gil
    Staender, Sonja
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB72 - AB72
12345